Two areas of recent interest for patients and families of children who have undergone a liver transplant are:
With the help of investigators at the Thomal E. Starzl Transplant Institute and around the country, we have designed simple blood tests that may help determine why some patients need more immunosuppression and some need less.
These tests measure different immune cell types, the patient’s genetic ability to cause immune reactions, and the patient’s immune reactions to their new liver.
What is involved?
To participate, call your Children’s Hospital of Pittsburgh liver transplant
coordinator at
412-648-3200 and schedule a visit.
While some patients may require drug withdrawal due to infections or other emergency indications, other patients may be candidates for elective drug withdrawal after liver transplantation.
Immunosuppression is weaned as part of our ongoing clinical efforts to minimize the complications of immune suppressants. Weaning of immunosuppression is individually tailored to each patient.
What are the criteria for considering elective drug withdrawal?